Article
Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.
Chemistry & biology - 24 Nov 2008
Pei Ying, Mercier Richard W, Anday Jenine K, Thakur Ganesh A, Zvonok Alexander M, Hurst Dow, Reggio Patricia H, Janero David R, Makriyannis Alexandros
Abstract excerpt
The extensive physiological influence of transmission through the CB2 cannabinoid receptor makes this G protein-coupled receptor (GPCR) a promising therapeutic target for treating neuropathic pain, inflammation, and immune disorders. However, there is little direct structural information pertaining to either GPCR or CB2-receptor ligand recognition and activation. The present work helps characterize experimentally...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
